Fidelity Investments’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NXTC
O
SI
CCC
LFCM
TCM
AI
Fidelity Investments's NXTC Position: Q4 2023 in Review
Fidelity Investments sold out of NextCure (NXTC) in Q4 2023, closing a stake of 386 shares — an estimated $5.97K sold.
Fidelity Investments first reported a position in NXTC in Q4 2019 and held it in 15 quarters. The position peaked at $8.36M in Q4 2019. 43 funds tracked by Wall St. Rank hold NXTC as of Q4 2023.
- Fidelity Investments reported no remaining NextCure position as of Q4 2023 after selling out during the quarter.
- Fidelity Investments sold 386 NextCure shares in Q4 2023, an estimated $5.97K.
- Fidelity Investments first reported a position in NextCure in Q4 2019 and held it in 15 quarters.
- Fidelity Investments's NextCure position peaked at $8.36M in Q4 2019.
- 43 funds tracked by Wall St. Rank held NextCure as of Q4 2023.
Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.